Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Further research is needed to develop effective cancer prevention strategies.

Gefitinib can cause rare scarring hair loss.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

The treatment combination is effective and generally safe for lung cancer.

Cetuximab can cause eyelash growth, which is rare but manageable.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Gefitinib can cause hair and eyebrow darkening.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

The treatment was effective and tolerable for advanced gastric cancer.

Cancer treatments often cause skin, nail, and hair problems.

Drug misuse can cause serious eye infections and other severe side effects.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Tofacitinib might be used to treat hair loss.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.

Clofazimine effectively treated ashy dermatosis in a patient.

Most patients experienced significant but reversible hair loss during treatment.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.